| Name | Title | Contact Details |
|---|
ClearView Healthcare Partners is a global strategy consulting firm focused on the life sciences sector. Founded in 2007 in Boston, the company provides strategic advice across various therapeutic areas and technologies. ClearView combines scientific expertise with analytical rigor to help clients develop growth strategies at the product, franchise, and corporate levels. The firm operates globally, with offices in North America, including Boston, New York, and San Francisco, and has expanded into Europe with locations in London and Zurich. ClearView offers a range of services, including market analysis, launch strategy development, pricing strategies, and advanced analytics, tailored to support pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as investors in the life sciences sector. ClearView is guided by principles of clarity, quality, and collaboration, ensuring high-quality solutions developed in partnership with clients. The company fosters an intellectually stimulating environment and attracts motivated individuals through a competitive hiring process.
With decades of experience working with world-class athletes, brands, and media production, we provide a single source for talent representation, brand marketing, content production and more. Leveraging our decades of industry knowledge and expertise, our goal is to create strategies and pathways for both our athlete and brand partners so they can dream big and reach their goals.
LG Chem is a leading global chemical company with a diversified business portfolio in the key areas of petrochemicals, advanced materials, and life sciences. The company manufactures a wide range of products from high-value added petrochemicals to renewable plastics, specializing in cutting-edge electronic and battery materials such as cathodes, as well as drugs and vaccines to deliver differentiated solutions for its customers. LG Chem is committed to reaching carbon-neutral growth by 2030 and net-zero emissions by 2050 by managing the impacts of climate change and making positive contributions to society through renewable energy and responsible supply chains.
A-MAX Auto Insurance is a Texas-based insurance provider founded in 2002, with its headquarters in Dallas. The company specializes in affordable insurance solutions and has rapidly expanded to operate over 200 offices across Texas. In 2022, A-MAX entered the California market by acquiring Sameday Insurance, adding 10 locations in Southern California. A-MAX offers a wide range of insurance products, including auto insurance for cars, motorcycles, boats, RVs, and commercial vehicles. They also provide property insurance for homeowners, renters, and mobile homes, along with specialized services such as SR-22 certificates, Mexico tourist insurance, surety bonds, and notary services. Additionally, A-MAX has commercial solutions, including general liability and commercial auto insurance. The company operates two subsidiaries in Texas: ALPA Auto Insurance and Preferred Coverage Insurance Agency, catering to both non-standard and commercial/personal insurance needs. A-MAX focuses on delivering flexible, customer-centric service to individual consumers and businesses.
Tech Observer is a global Contract Research Organization (CRO) founded in 2005, with its headquarters in Paramus, New Jersey, and additional offices in New Delhi, Mumbai, and Singapore. The company specializes in clinical development support for the pharmaceutical, biotechnology, and medical device industries, extending its reach through local partners across the Asia-Pacific region. The company offers a comprehensive range of services that encompass the entire clinical research process. These include managing clinical trials, clinical data management, biostatistics and SAS programming, medical writing, post-marketing clinical studies, and staffing services. Tech Observer is ISO 9001:2008 and ISO 14155:2011 certified, demonstrating its commitment to quality and regulatory compliance. With a workforce of around 400 professionals, the company serves over 50 clients in more than 30 countries, focusing on various therapeutic areas such as oncology, cardiology, and infectious diseases. Tech Observer also emphasizes innovation with solutions like its AI-driven clinical trial risk tool, MyRBQM, and promotes diversity and professional growth within its team.